Wim van den Broek MBA/LinkedIn
Oct 28, 2025, 06:59
Wim van den Broek Attended ECTH in Prague
Wim van den Broek, CEO/CFO of Enzyre B.V., shared a post on LinkedIn:
“Enzyre B.V. attending European Congress on Thrombosis and Haemostasis (ECTH) in Prague.”
Stay informed with Hemostasis Today.
-
Feb 12, 2026, 11:52Miriam Mwachinga: Let’s Focus More on Rare Diseases and Their Impact on Quality of Life
-
Feb 12, 2026, 11:32Sophie Titoulet Announces Challenge Plasma 2026: The Art of Giving Regularly
-
Feb 12, 2026, 11:19Goran Mitulović: Proteomics and Mass Spectroscopy Identified The Cause of VITT
-
Feb 12, 2026, 11:14Leonardo Roever: CHR as a Composite Biomarker for Stroke Risk Stratification
-
Feb 12, 2026, 11:10Filippo Cademartiri: Can AI Reduce Diagnostic Errors in Low-Resource Settings?
-
Feb 12, 2026, 11:06Murad Ali: An Important Marker of Active Clot Formation and Fibrinolysis
-
Feb 12, 2026, 11:02Right Chukwuneme: Daltaparin vs Apixaban – Efficacy or Safety Paradox?
-
Feb 12, 2026, 10:57Muntadhar Al Moosawi Gives A Talk on Chromogenic FVIII in Hemophilia A at WHX Labs Dubai
-
Feb 12, 2026, 10:52Dario Bongiovanni: Meeting Wrap-Up of ESC Heart and Stroke and EuroThrombosis 2025